Physician profile
Kirk S Hutton
NPI 1861406837
$14,506.68
in general payments reported to CMS, 2019-2025
12 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $63.64 · 2021: $1,948 · 2022: $512 · 2023: $146 · 2024: $1,242 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $977 · Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $977.30 |
| Food and Beverage | $750.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $7,055.78 | 2019 | |
| Arthrex, INC. | $2,967.79 | 2019-2024 | Arthrex |
| Conetic Solutions, INC. | $2,250.71 | 2021-2024 | |
| Depuy Synthes Sales INC. | $802.38 | 2019 | |
| Rsw Medical Company, INC. | $402.08 | 2019 | |
| Stryker Corporation | $394.41 | 2019-2025 | Aequalis Ascend Flex, Aequalis Perform+ |
| Ethicon US, LLC | $178.55 | 2022 | |
| Zimmer Biomet Holdings, INC. | $159.51 | 2019-2020 | |
| Medacta USA, INC. | $125.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $97.19 | 2022 | |
| Smith+Nephew, INC. | $58.57 | 2020-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Fx Shoulder Solutions, INC | $14.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Hutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.